160 related articles for article (PubMed ID: 1910928)
1. [Clinical diagnosis of Duchenne muscular dystrophy using anti-dystrophin antibodies].
Arahata K
No To Shinkei; 1991 May; 43(5):411-9. PubMed ID: 1910928
[No Abstract] [Full Text] [Related]
2. ELISA quantitation of dystrophin for the diagnosis of Duchenne and Becker muscular dystrophies.
Byers TJ; Neumann PE; Beggs AH; Kunkel LM
Neurology; 1992 Mar; 42(3 Pt 1):570-6. PubMed ID: 1549217
[TBL] [Abstract][Full Text] [Related]
3. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies.
Matsumura K; Campbell KP
Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699
[TBL] [Abstract][Full Text] [Related]
4. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
5. [Genetic counselling for Duchenne muscular dystrophy].
Ousawa M; Saito K; Ikeya K; Fukuyama Y
No To Shinkei; 1991 May; 43(5):429-41. PubMed ID: 1910929
[No Abstract] [Full Text] [Related]
6. The concomitant use of dystrophin and utrophin/dystrophin related protein antibodies to reduce misdiagnosis of Duchenne/Becker muscular dystrophy.
Khurana TS; Specht LA; Beggs AH; Tomé FM; Letureq F; Chevallay M; Chafey P; Kunkel LM
Biochem Biophys Res Commun; 1997 Dec; 241(2):232-5. PubMed ID: 9425255
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and carrier detection in a Duchenne muscular dystrophy family by multiplex polymerase chain reaction and microsatellite analysis.
Jongpiputvanich S; Norapucsunton T; Mutirangura A
J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S15-21. PubMed ID: 9071063
[TBL] [Abstract][Full Text] [Related]
8. [[Study of dystrophin in muscular dystrophy--why and when?].
Sariola H; Koistinen H; Wallgren-Pettersson C; Rapola J
Duodecim; 1992; 108(6):591-6. PubMed ID: 1366119
[No Abstract] [Full Text] [Related]
9. Detection of gene deletions by PCR analysis in a Malaysian patient with Duchenne muscular dystrophy.
Lee MK; Manonmani V; Arahata K
Med J Malaysia; 1993 Mar; 48(1):46-50. PubMed ID: 8341171
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of Duchenne muscular dystrophy by use of a conformational polymorphism in the absence of DNA from an affected boy.
Tuffery S; Moine P; Sarda P; Lefort G; Boulot P; Demaille J; Claustres M
Genet Couns; 1994; 5(2):183-5. PubMed ID: 7917130
[TBL] [Abstract][Full Text] [Related]
11. [DNA diagnosis of Duchenne muscular dystrophy].
Matsumoto T
No To Shinkei; 1991 May; 43(5):421-8. PubMed ID: 1680358
[No Abstract] [Full Text] [Related]
12. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
Shomrat R; Gluck E; Legum C; Shiloh Y
Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
[TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy.
Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M
Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538
[TBL] [Abstract][Full Text] [Related]
14. Genetic counseling of isolated carriers of Duchenne muscular dystrophy.
Hoffman EP; Pegoraro E; Scacheri P; Burns RG; Taber JW; Weiss L; Spiro A; Blattner P
Am J Med Genet; 1996 Jun; 63(4):573-80. PubMed ID: 8826437
[TBL] [Abstract][Full Text] [Related]
15. Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection.
Prior TW; Papp AC; Snyder PJ; Sedra MS; Western LM; Bartolo C; Moxley RT; Mendell JR
Am J Med Genet; 1994 Mar; 50(1):68-73. PubMed ID: 8160755
[TBL] [Abstract][Full Text] [Related]
16. [Microsatellite analysis of Duchenne muscular dystrophy].
Fujishita S; Shibuya N
Nihon Rinsho; 1997 Dec; 55(12):3131-6. PubMed ID: 9436423
[TBL] [Abstract][Full Text] [Related]
17. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
Colomer Oferil J; Vila Torres J; Huezo Montoya C
Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
[TBL] [Abstract][Full Text] [Related]
18. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
Navarro C
Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
[TBL] [Abstract][Full Text] [Related]
19. Duchenne muscular dystrophy: the gene and the protein.
Love DR; Davies KE
Mol Biol Med; 1989 Feb; 6(1):7-17. PubMed ID: 2666821
[No Abstract] [Full Text] [Related]
20. Can a newer MR contrast agent be used to monitor disease progression in muscular dystrophy?
Unger EC
Radiology; 2009 Jan; 250(1):1-3. PubMed ID: 19092081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
